 Androgen responses increased endogenous insulin levels hyperandrogenic normal cycling women responses hyperandrogenic polycystic ovarian disease PCOD normal women acute endogenous insulin elevation Standard intravenous glucose tolerance tests IVGTTs tolbutamide injection minutes IVGTTs Polycystic ovarian disease patients untreated state weeks ovarian androgen suppression leuprolide acetate rest period weeks antiandrogen therapy spironolactone Normal women early follicular midcycle luteal phases single cycle acute rise insulin serum testosterone androstenedione levels PCOD normal women significant rise dehydroepiandrosterone sulfate modified IVGTTs hyperandrogenic normal cycling women results supportive theory acts ovary androgen production short time course insulin elevation IVGTT